Pparδ agonist 5
This compound is a selective, orally bioavailable PPARδ agonist (EC50 = 0.335 μM) with improved selectivity over GW0742. Research indicates it can enhance bone density and microarchitecture in vivo, making it a useful tool for studying metabolic bone disorders and PPARδ signaling in both cellular and animal models.
Product Specifications
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Molecular Formula
C23H21F3N2O2S
Molecular Weight
446.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr0906-500gEcoli 500 µg (E. coli)
Recombinant Pseudomonas Aeruginosa rplY Protein (aa 1-204) (strain PA7)
Sign In for Pricing
View Details 
RE2528H-01 48 Tests
Human DAG1 (Dystrophin Associated Glycoprotein 1) ELISA Kit
Sign In for Pricing
View Details RE2528H-02 96 Tests
Human DAG1 (Dystrophin Associated Glycoprotein 1) ELISA Kit
Sign In for Pricing
View Details 
bs-9837R-PE-Cy5 100 µL
C17orf104 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details MBS2804829-01 48 Tests
Mouse Solute carrier family 12 member 5 (SLC12A5) ELISA Kit
Sign In for Pricing
View Details